Abstract:The TP53 gene encodes p53, a transcription factor involved in tumor suppression. However, TP53 also encodes other protein isoforms, some of which can disrupt the tumor suppressor functions of p53 even in the absence of TP53 mutations. In particular, elevated levels of the Δ133 TP53 mRNA are detected in many cancer types and can be associated with poorer disease-free survival. We investigated the mechanisms of action of the two proteins translated from the Δ133 TP53 mRNA: the Δ133p53α and Δ160p53α isoforms, both of which retain the oligomerization domain of p53. We discovered that the Δ133p53α and Δ160p53α isoforms adopt an altered conformation compared to full-length p53, exposing the PAb240 epitope (RHSVVV), which is inaccessible to the PAb240 antibody in the functional conformation of p53 (reactive to PAb1620). The Δ133p53α and/or Δ160p53α isoforms form hetero-oligomers with p53, regulating the stability, the conformation and the transcriptional activity of the p53 hetero-oligomers. Under basal conditions, Δ133p53α and Δ160p53α, in complex with p53, prevent proteasome-dependent degradation leading to the accumulation of PAb240 reactive Δ133p53α/Δ160p53α/p53 hetero-oligomers without increasing p53 transcriptional activity. Conversely, depletion of endogenous Δ133p53α isoforms in human fibroblasts is sufficient to restore p53 transcriptional activity, towards p53-target genes involved in cell cycle arrest. In the DNA damage response (DDR), PAb240 reactive Δ133p53α/Δ160p53α/p53 hetero-oligomers are highly phosphorylated at Ser15 compared to PAb1620-reactive p53 complexes devoid of Δ133p53α and Δ160p53α. This suggests that PAb240-reactive p53 hetero-oligomers integrate DNA damage signals. Δ133p53α accumulation is a late event in the DDR that depends on p53, but not on its transcriptional activation. The formation of Δ133p53α and p53 complexes increases at later DDR stages. We propose that Δ133p53α isoforms regulate p53 conformation as part of the normal p53 biology, modulating p53 activity and thereby adapting the cellular response to the cell signals.

Compensatory Expression of P73 in PARP-Deficient Mouse Fibroblasts As Response to a Reduced Level of Regularly Spliced Wild-Type P53 Protein

P73 Coordinates with Δ133p53 to Promote DNA Double-Strand Break Repair

Evaluating the Influence of a G-Quadruplex Prone Sequence on the Transactivation Potential by Wild-Type and/or Mutant P53 Family Proteins through a Yeast-Based Functional Assay

P53 Inactivation Upregulates P73 Expression Through E2F-1 Mediated Transcription.

A balancing act: orchestrating amino-truncated and full-length p73 variants as decisive factors in cancer progression

PARP is important for genomic stability but dispensable in apoptosis

Modulation of (±)-anti-BPDE mediated p53 accumulation by inhibitors of protein kinase C and poly(ADP-ribose) polymerase

Ser18 and 23 Phosphorylation is Required for P53-Dependent Apoptosis and Tumor Suppression

Epigenetic modification in the expression of p73 p73 - epigenetic target for anticancer therapy

Tumor suppressor p73 transcriptionally regulates to impede its priming of extrinsic apoptosis while a “switcher compound” degrades c-FLIP protein

Cell Type- and Promoter-specific Roles of Ser18 Phosphorylation in Regulating p53 Responses

Stabilization of p53 by CP-31398 inhibits ubiquitination without altering phosphorylation at serine 15 or 20 or MDM2 binding.

Differential effect of plakoglobin in restoring the tumor suppressor activities of p53-R273H vs. p53-R175H mutants

P53-Mediated DNA Repair Responses to UV Radiation: Studies of Mouse Cells Lacking P53, P21, And/orgadd45 Genes

Interaction of p53 with the Δ133p53α and Δ160p53α isoforms regulates p53 conformation and transcriptional activity

Adaptive genetic mechanisms in mammalian Parp1 locus

Mutation of Mouse P53 Ser23 and the Response to Dna Damage

Selective Down-Regulation of Nuclear Poly(ADP-Ribose) Glycohydrolase

Loss of the p12 subunit of DNA polymerase delta leads to a defect in HR and sensitization to PARP inhibitors

Acetylation of mouse p53 at lysine 317 negatively regulates p53 apoptotic activities after DNA damage.

The C-terminus of Gain-of-Function Mutant p53 R273H Is Required for Association with PARP1 and Poly-ADP-Ribose